Name: UMIN ID:
Unique ID issued by UMIN | UMIN000029913 |
---|---|
Receipt number | R000034172 |
Scientific Title | A Phase 3 Multicenter, Randomized, Double-Blind and Placebo-Controlled Study, and Open Study of KW-0761 in Patients With HTLV-1 Associated Myelopathy (HAM) |
Date of disclosure of the study information | 2017/11/13 |
Last modified on | 2022/04/07 16:51:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/11/10 13:41:32 | ||
2 | Update | 2017/11/13 17:14:02 | Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
3 | Update | 2018/05/22 17:00:54 | Recruitment status |
|
4 | Update | 2022/04/07 10:56:57 | Number of participants that the trial has enrolled |
|
5 | Update | 2022/04/07 16:48:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Organization Organization Zip code Address Address TEL Organization Organization Institute Institute Organization Organization Address Address Tel |
|
6 | Update | 2022/04/07 16:51:42 | Recruitment status Date of IRB Last follow-up date |